Free Trial

Ceva (CEVA) Financials

Ceva logo
$25.59 -0.73 (-2.77%)
Closing price 04:00 PM Eastern
Extended Trading
$25.12 -0.47 (-1.84%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Ceva

Annual Income Statements for Ceva

This table shows Ceva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
6.27 13 17 0.57 0.03 -2.38 0.40 -23 -12 -8.79 -11
Consolidated Net Income / (Loss)
6.27 13 17 0.57 0.03 -2.38 0.40 -23 -12 -8.79 -11
Net Income / (Loss) Continuing Operations
6.27 13 17 0.57 0.03 -2.38 2.40 -14 -18 -8.79 -11
Total Pre-Tax Income
7.38 16 19 1.30 1.37 2.52 9.22 4.20 -8.21 -2.76 -4.69
Total Operating Income
6.31 14 16 -1.25 -1.92 -0.76 7.04 3.90 -13 -7.55 -11
Total Gross Profit
54 67 81 70 77 90 103 105 86 94 95
Total Revenue
59 73 88 78 87 100 114 121 97 107 110
Operating Revenue
59 73 88 78 87 100 114 121 97 107 110
Total Cost of Revenue
5.42 6.09 6.95 7.95 10 11 10 15 12 13 14
Operating Cost of Revenue
5.42 6.09 6.95 7.95 10 11 10 15 12 13 14
Total Operating Expenses
48 52 65 71 79 90 96 102 99 102 107
Selling, General & Admin Expense
8.18 8.57 10 10 12 14 13 14 15 17 18
Marketing Expense
10 12 13 12 12 12 12 11 11 13 13
Research & Development Expense
28 31 40 48 53 62 69 70 73 72 75
Amortization Expense
1.30 1.24 1.24 0.90 1.92 2.31 2.30 2.03 0.59 0.60 0.60
Total Other Income / (Expense), net
1.07 2.04 3.03 2.55 3.29 3.28 2.18 0.30 5.26 4.79 6.66
Interest & Investment Income
1.07 2.04 3.03 2.55 3.29 3.28 0.20 2.81 5.26 4.88 6.91
Other Income / (Expense), net
- - - - - 0.00 1.98 -2.51 -0.00 -0.09 -0.26
Income Tax Expense
1.11 3.33 1.87 0.73 1.34 4.90 6.82 18 10 6.03 5.95
Net Income / (Loss) Discontinued Operations
- - - - - - -2.00 -9.31 6.56 0.00 0.00
Basic Earnings per Share
$0.31 $0.63 $0.78 $0.03 $0.00 ($0.11) $0.02 ($1.00) ($0.51) ($0.37) ($0.44)
Weighted Average Basic Shares Outstanding
20.48M 20.85M 21.77M 22.03M 21.93M 22.11M 22.82M 23.17M 23.48M 23.61M 24.30M
Diluted Earnings per Share
$0.30 $0.61 $0.75 $0.03 $0.00 ($0.11) $0.02 ($1.00) ($0.51) ($0.37) ($0.44)
Weighted Average Diluted Shares Outstanding
20.99M 21.57M 22.56M 22.50M 22.32M 22.11M 23.25M 23.17M 23.48M 23.61M 24.30M
Weighted Average Basic & Diluted Shares Outstanding
20.20M 20.80M 21.80M 22.06M 22.19M 22.81M 23.20M 23.42M 23.63M 23.81M 27.75M

Quarterly Income Statements for Ceva

This table shows Ceva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-5.45 -0.29 -1.31 -1.74 -3.33 -3.70 -2.51 -1.10 -4.46 -2.91 -2.30
Consolidated Net Income / (Loss)
-5.45 -0.29 -1.31 -1.74 -3.33 -3.70 -2.51 -1.10 -4.46 -2.91 -2.30
Net Income / (Loss) Continuing Operations
-5.45 -0.29 -1.31 -1.74 -3.33 -3.70 -2.51 -1.10 -4.46 -2.91 -2.30
Total Pre-Tax Income
-3.76 1.31 -0.30 -0.00 -2.34 -2.57 -0.84 1.05 -3.14 -1.07 -1.23
Total Operating Income
-4.96 -0.04 -2.62 0.07 -4.38 -4.48 -2.08 -0.40 -5.09 -2.08 -3.52
Total Gross Profit
20 26 23 26 21 22 25 28 23 25 25
Total Revenue
22 28 27 29 24 26 28 31 27 29 29
Operating Revenue
22 28 27 29 24 26 28 31 27 29 29
Total Cost of Revenue
2.50 2.93 3.96 3.37 3.49 3.55 3.39 3.73 3.73 3.65 4.25
Operating Cost of Revenue
2.50 2.93 3.96 3.37 3.49 3.55 3.39 3.73 3.73 3.65 4.25
Total Operating Expenses
25 26 26 26 25 27 27 28 28 27 28
Selling, General & Admin Expense
3.57 3.54 4.64 5.13 3.93 4.38 4.38 5.40 4.66 4.74 6.15
Marketing Expense
2.82 3.10 3.09 3.63 3.45 3.32 3.01 3.48 3.77 3.28 3.94
Research & Development Expense
18 19 18 17 18 19 20 19 20 19 18
Amortization Expense
0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.12 0.11 0.11
Total Other Income / (Expense), net
1.20 1.35 2.32 -0.08 2.05 1.91 1.25 1.45 1.94 1.00 2.29
Interest & Investment Income
1.26 1.41 2.30 -0.08 2.10 2.12 1.25 1.45 1.88 0.98 2.30
Other Income / (Expense), net
-0.06 -0.06 0.02 0.00 -0.05 -0.21 0.00 0.00 0.06 0.02 -0.02
Income Tax Expense
1.69 1.60 1.01 1.74 0.99 1.14 1.67 2.15 1.32 1.84 1.07
Basic Earnings per Share
- - - ($0.07) ($0.14) ($0.15) ($0.10) - ($0.16) ($0.10) ($0.08)
Weighted Average Basic Shares Outstanding
23.51M 23.63M 23.68M 23.61M 23.76M 23.90M 23.94M 24.30M 27.68M 28.00M 28.32M
Weighted Average Diluted Shares Outstanding
23.58M 23.69M 23.63M 23.61M 23.92M 23.88M 24.02M 24.30M 27.86M 28.15M 28.53M
Weighted Average Basic & Diluted Shares Outstanding
23.58M 23.69M 23.63M 23.81M 23.92M 23.88M 24.02M 27.75M 27.86M 28.15M 28.53M

Annual Cash Flow Statements for Ceva

This table details how cash moves in and out of Ceva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2.74 -0.51 3.34 0.52 0.54 -1.66 12 -12 2.00 -4.79 22
Net Cash From Operating Activities
19 14 24 8.61 9.67 15 26 6.92 -6.33 3.47 -3.36
Net Cash From Continuing Operating Activities
19 14 24 8.61 9.67 15 26 6.92 -6.33 3.47 -3.36
Net Income / (Loss) Continuing Operations
6.27 13 17 0.57 0.03 -2.38 0.40 -23 -12 -8.79 -11
Consolidated Net Income / (Loss)
6.27 13 17 0.57 0.03 -2.38 0.40 -23 -12 -8.79 -11
Depreciation Expense
1.06 1.40 2.01 2.92 3.10 3.23 3.18 3.19 2.89 3.05 3.44
Amortization Expense
2.41 2.30 2.42 2.02 2.72 3.03 4.22 4.77 1.87 1.09 0.08
Non-Cash Adjustments To Reconcile Net Income
5.76 -4.80 9.14 10 12 13 17 18 3.68 16 17
Changes in Operating Assets and Liabilities, net
3.88 2.46 -6.13 -7.02 -7.81 -1.64 1.21 4.16 -2.89 -8.36 -14
Net Cash From Investing Activities
-9.65 -21 -29 9.83 -2.44 -15 -17 -15 11 -2.45 -34
Net Cash From Continuing Investing Activities
-9.65 -21 -29 9.83 -2.44 -15 -17 -15 11 -2.45 -34
Purchase of Property, Plant & Equipment
-2.18 -2.39 -4.14 -3.32 - -2.94 -2.19 -3.50 -2.88 -3.71 -2.92
Acquisitions
- 0.00 0.00 -1.96 -11 0.00 -30 0.00 -3.60 0.00 0.00
Purchase of Investments
-30 -44 -55 -20 -27 -56 -39 -50 -40 -47 -106
Divestitures
- - - - -7.36 - 0.00 0.00 31 0.54 3.47
Sale and/or Maturity of Investments
28 29 33 23 40 32 36 21 23 40 73
Other Investing Activities, net
-5.88 -3.88 -2.58 11 6.09 12 18 17 4.00 8.00 -0.71
Net Cash From Financing Activities
-6.95 6.20 7.49 -18 -6.68 -2.11 3.24 -3.31 -2.77 -5.57 59
Net Cash From Continuing Financing Activities
-6.95 6.20 7.49 -18 -6.68 -2.11 3.24 -3.31 -2.77 -5.57 59
Repurchase of Common Equity
-10 -3.42 0.00 -20 - -4.78 0.00 -6.79 -6.16 -8.46 -7.15
Issuance of Common Equity
6.71 9.62 7.49 2.25 -6.68 2.87 3.24 3.48 3.39 2.88 66
Cash Income Taxes Paid
2.19 3.29 5.20 4.29 5.06 4.73 9.18 10 7.40 6.26 4.18

Quarterly Cash Flow Statements for Ceva

This table details how cash moves in and out of Ceva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-2.07 9.93 -29 5.27 0.32 10 -12 23 -19 23 -15
Net Cash From Operating Activities
-7.35 2.38 0.40 8.04 -7.40 1.18 -5.86 8.72 -4.89 5.83 1.51
Net Cash From Continuing Operating Activities
-7.35 8.83 -17 8.04 -7.40 1.18 -5.86 8.72 -4.89 5.83 1.51
Net Income / (Loss) Continuing Operations
-5.45 -0.29 -1.31 -1.74 -3.33 -3.70 -2.51 -1.10 -4.46 -2.91 -2.30
Consolidated Net Income / (Loss)
-5.45 -0.29 -1.31 -1.74 -3.33 -3.70 -2.51 -1.10 -4.46 -2.91 -2.30
Depreciation Expense
0.70 0.74 0.71 0.89 0.65 0.90 0.95 0.94 0.69 0.63 0.66
Amortization Expense
0.28 0.47 -0.76 -0.01 -0.04 0.21 0.21 -0.55 0.18 -0.01 0.13
Non-Cash Adjustments To Reconcile Net Income
1.04 11 -11 9.91 3.52 8.00 5.43 5.03 6.72 6.44 4.65
Changes in Operating Assets and Liabilities, net
-3.92 -2.77 -4.99 -1.01 -8.21 -4.22 -9.93 4.40 -8.01 1.67 -1.62
Net Cash From Investing Activities
5.10 3.09 -9.25 -1.39 6.23 15 -6.18 -49 -16 17 -18
Net Cash From Continuing Investing Activities
5.10 3.09 -9.25 -1.39 6.23 15 -6.18 -49 -16 17 -18
Purchase of Property, Plant & Equipment
-1.66 -0.61 -0.41 -1.03 -0.31 -0.69 -0.43 -1.49 -2.32 -0.63 -1.08
Purchase of Investments
-13 -17 -11 -5.56 -29 -1.63 -19 -57 -25 -24 -71
Sale and/or Maturity of Investments
19 13 2.51 5.20 36 14 13 9.49 14 41 54
Net Cash From Financing Activities
0.28 -2.00 -2.85 -1.00 1.36 -5.89 0.61 63 1.55 - 1.48
Net Cash From Continuing Financing Activities
0.28 -2.00 -2.85 -1.00 1.36 -5.89 0.61 63 1.55 - 1.48
Issuance of Common Equity
1.55 - 1.33 - 1.36 0.27 1.59 63 1.55 - 1.48
Effect of Exchange Rate Changes
- - - -0.39 0.13 - -0.38 - -0.08 - 0.07
Cash Income Taxes Paid
0.87 0.64 2.42 2.33 1.70 1.54 -1.34 2.28 1.96 2.20 1.26

Annual Balance Sheets for Ceva

This table presents Ceva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
213 242 277 277 297 307 329 308 304 309 388
Total Current Assets
106 145 159 177 179 168 189 178 209 216 285
Cash & Equivalents
19 18 22 22 23 21 33 20 23 18 41
Short-Term Investments
48 62 83 77 65 89 90 112 133 143 179
Accounts Receivable
4.07 15 16 26 28 31 27 30 30 37 49
Prepaid Expenses
4.02 3.15 3.75 5.26 5.66 6.21 6.67 6.79 13 15 13
Other Current Assets
31 46 34 46 57 20 31 6.11 11 2.03 2.10
Plant, Property, & Equipment, net
3.73 4.81 6.93 7.34 7.88 7.59 6.77 6.62 6.73 6.88 7.05
Total Noncurrent Assets
103 93 111 93 111 132 133 124 88 86 96
Long-Term Investments
1.81 1.81 1.81 0.94 0.94 0.94 2.92 0.41 0.41 0.31 0.06
Goodwill
47 47 47 47 51 51 75 57 58 58 58
Intangible Assets
4.21 2.98 1.74 2.70 13 11 15 2.39 2.97 1.88 1.04
Noncurrent Deferred & Refundable Income Taxes
1.63 2.25 3.64 5.92 11 11 16 8.48 1.61 1.46 0.26
Other Noncurrent Operating Assets
49 39 57 36 35 58 25 31 25 24 37
Total Liabilities & Shareholders' Equity
213 242 277 277 297 307 329 308 304 309 388
Total Liabilities
27 31 32 31 46 46 52 50 40 42 52
Total Current Liabilities
19 23 23 22 26 28 35 33 27 31 29
Accounts Payable
0.69 0.57 0.39 0.63 0.70 0.89 1.46 1.86 1.15 1.13 2.42
Accrued Expenses
3.63 4.02 3.93 4.34 3.75 3.84 4.03 6.55 5.80 6.24 5.18
Current Deferred Revenue
2.76 6.26 4.40 3.59 3.64 2.43 8.66 3.10 3.02 3.60 3.50
Current Employee Benefit Liabilities
12 12 14 13 16 18 18 18 14 17 16
Other Current Liabilities
- - - 0.00 2.39 2.97 3.27 2.68 2.51 2.60 1.74
Total Noncurrent Liabilities
7.57 8.35 9.35 9.63 19 18 16 16 13 12 23
Other Noncurrent Operating Liabilities
7.57 8.35 9.35 9.63 19 18 16 15 13 12 23
Total Equity & Noncontrolling Interests
186 212 245 246 251 261 277 259 264 267 336
Total Preferred & Common Equity
186 212 245 246 251 261 277 259 264 267 336
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Common Equity
186 212 245 246 251 261 277 259 264 267 336
Common Stock
209 212 217 223 228 233 235 243 252 260 338
Retained Earnings
30 39 54 63 62 57 55 32 20 11 -0.02
Treasury Stock
-52 -40 -26 -39 -39 -30 -14 -9.90 -5.62 -3.22 -1.59
Accumulated Other Comprehensive Income / (Loss)
-0.42 -0.50 -0.59 -1.11 0.09 0.48 -0.37 -6.25 -2.33 -1.33 0.08

Quarterly Balance Sheets for Ceva

This table presents Ceva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
300 296 301 300 305 310 303 306 388 392 391
Total Current Assets
175 171 206 207 211 217 209 214 281 283 281
Cash & Equivalents
28 17 21 25 13 19 29 17 21 44 30
Short-Term Investments
98 104 127 132 143 137 126 132 189 171 186
Accounts Receivable
32 31 34 36 39 41 37 50 49 47 46
Prepaid Expenses
7.75 6.83 13 13 14 18 15 13 16 16 14
Other Current Assets
10 10 11 2.11 2.01 2.05 2.85 2.81 5.14 5.15 5.12
Plant, Property, & Equipment, net
6.87 6.73 7.16 6.84 6.88 6.58 6.48 6.01 9.01 8.78 9.16
Total Noncurrent Assets
118 118 89 86 87 86 88 86 98 100 100
Long-Term Investments
0.17 0.33 0.35 0.29 0.31 0.26 0.05 0.05 0.12 0.14 0.13
Goodwill
77 58 58 58 58 58 58 58 58 58 58
Intangible Assets
6.91 3.25 2.69 2.41 2.13 1.67 1.46 1.25 0.87 0.70 0.53
Noncurrent Deferred & Refundable Income Taxes
8.94 9.99 1.24 1.32 1.69 1.17 1.63 1.40 0.27 0.23 0.30
Other Noncurrent Operating Assets
25 22 26 24 25 25 26 25 39 41 41
Total Liabilities & Shareholders' Equity
300 296 301 300 305 310 303 306 388 392 391
Total Liabilities
42 39 39 37 39 41 37 37 50 52 48
Total Current Liabilities
26 26 27 25 28 29 24 25 27 28 26
Accounts Payable
1.10 1.22 1.80 1.09 1.96 2.53 1.77 1.78 2.39 1.54 1.24
Accrued Expenses
5.56 5.46 4.98 6.05 6.01 5.51 4.76 5.24 4.30 4.39 4.71
Current Deferred Revenue
3.79 3.99 2.48 2.83 3.42 2.95 3.21 3.05 2.97 2.69 3.44
Current Employee Benefit Liabilities
13 12 15 12 14 16 13 13 15 17 14
Other Current Liabilities
2.90 2.57 - - 2.57 2.00 1.61 1.24 2.79 2.66 2.80
Total Noncurrent Liabilities
16 14 12 12 11 12 13 13 23 24 22
Other Noncurrent Operating Liabilities
16 12 8.81 8.67 8.78 12 13 13 23 24 22
Total Equity & Noncontrolling Interests
259 257 262 264 266 269 266 269 338 340 342
Total Preferred & Common Equity
259 257 262 264 266 269 266 269 338 340 342
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
259 257 262 264 266 269 266 269 338 340 342
Common Stock
244 249 253 254 257 263 268 270 343 348 355
Retained Earnings
21 16 15 14 13 7.36 3.66 1.10 -4.48 -7.39 -9.69
Treasury Stock
-1.46 -3.00 -2.53 -1.92 -2.94 0.00 -5.87 -2.55 0.00 0.00 0.00
Accumulated Other Comprehensive Income / (Loss)
-5.58 -5.47 -2.72 -2.89 -0.96 -1.11 0.34 0.20 -0.66 -0.86 -2.90

Annual Metrics And Ratios for Ceva

This table displays calculated financial ratios and metrics derived from Ceva's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
20,443,050.00 21,230,589.00 21,974,975.00 21,902,376.00 21,992,936.00 22,250,217.00 22,973,852.00 - - - 24,017,805.00
DEI Adjusted Shares Outstanding
20,443,050.00 21,230,589.00 21,974,975.00 21,902,376.00 21,992,936.00 22,250,217.00 22,973,852.00 - - - 24,017,805.00
DEI Earnings Per Adjusted Shares Outstanding
0.31 0.62 0.77 0.03 0.00 -0.11 0.02 - - - -0.44
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
5.36 11 14 -0.55 -0.04 0.72 1.83 -13 -9.43 -5.28 -7.94
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -4.98% -3.57% -1.98% -2.36%
Earnings before Interest and Taxes (EBIT)
6.31 14 16 -1.25 -1.92 -0.76 9.02 1.39 -13 -7.64 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
9.78 18 20 3.69 3.90 5.50 16 9.34 -8.71 -4.43 -8.09
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
6.90 -0.89 5.32 -7.30 -17 13 1.52 35 -15 -1.96 -20
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
117 129 138 145 163 150 150 102 108 105 117
Increase / (Decrease) in Invested Capital
-1.54 12 8.99 6.75 17 -12 0.31 -48 5.95 -3.32 12
Book Value per Share
$9.10 $9.96 $11.13 $11.23 $11.42 $11.73 $12.05 $11.16 $11.22 $11.28 $14.01
Tangible Book Value per Share
$6.62 $7.63 $8.93 $8.97 $8.49 $8.94 $8.15 $8.61 $8.62 $8.73 $11.54
Total Capital
186 212 245 246 251 261 277 259 264 267 336
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-69 -82 -106 -101 -89 -111 -126 -133 -156 -162 -220
Capital Expenditures (CapEx)
2.18 2.39 4.14 3.32 3.46 2.94 2.19 3.50 2.88 2.96 2.92
Debt-free, Cash-free Net Working Capital (DFCFNWC)
20 42 32 56 65 29 30 12 27 24 36
Debt-free Net Working Capital (DFNWC)
87 122 136 156 152 139 154 144 182 186 256
Net Working Capital (NWC)
87 122 136 156 152 139 154 144 182 186 256
Net Nonoperating Expense (NNE)
-0.91 -1.63 -2.73 -1.12 -0.07 3.10 1.43 10 2.45 3.50 2.70
Net Nonoperating Obligations (NNO)
-69 -82 -106 -101 -89 -111 -126 -157 -156 -162 -220
Total Depreciation and Amortization (D&A)
3.47 3.70 4.43 4.93 5.82 6.27 7.41 7.96 4.76 3.21 3.51
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.31 $0.63 $0.78 $0.03 $0.00 ($0.11) $0.02 ($1.00) ($0.51) ($0.37) ($0.44)
Adjusted Weighted Average Basic Shares Outstanding
20.48M 20.85M 21.77M 22.03M 21.93M 22.11M 22.82M 23.17M 23.48M 23.61M 24.30M
Adjusted Diluted Earnings per Share
$0.30 $0.61 $0.75 $0.03 $0.00 ($0.11) $0.02 ($1.00) ($0.51) ($0.37) ($0.44)
Adjusted Weighted Average Diluted Shares Outstanding
20.99M 21.57M 22.56M 22.50M 22.32M 22.11M 23.25M 23.17M 23.48M 23.61M 24.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
20.51M 21.48M 22.22M 22.06M 22.19M 22.81M 23.20M 23.42M 23.63M 23.81M 27.75M
Normalized Net Operating Profit after Tax (NOPAT)
5.36 11 14 -0.87 -1.35 -0.53 4.93 5.22 -9.43 -5.28 -7.94
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Ceva

This table displays calculated financial ratios and metrics derived from Ceva's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 23,806,655.00 23,916,361.00 23,882,243.00 24,017,805.00 27,754,136.00 27,859,369.00 28,154,072.00
DEI Adjusted Shares Outstanding
- - - - 23,806,655.00 23,916,361.00 23,882,243.00 24,017,805.00 27,754,136.00 27,859,369.00 28,154,072.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.14 -0.15 -0.11 -0.05 -0.16 -0.10 -0.08
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-15.95% 24.06% 13.02% 20.95% 9.85% -9.70% 4.33% - 11.46% 13.07% 2.39%
EBITDA Growth
-197.37% 127.94% -78.77% 150.05% 11.50% -485.79% 59.06% - -8.73% 57.18% -75.69%
EBIT Growth
-83.41% 98.30% -1.80% 102.84% 11.63% -4,943.01% 19.98% - -13.19% 56.25% -69.56%
NOPAT Growth
-89.31% 100.21% 3.42% 102.66% 11.65% -40,546.05% 20.58% - -16.04% 53.68% -68.71%
Net Income Growth
-11.82% 95.00% 73.55% -146.06% 38.93% -1,172.85% -91.38% - -34.02% 21.44% 8.29%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-44.80% 149.72% 131.15% 67.09% -0.73% -50.29% -1,568.42% - 34.02% 392.39% 125.81%
Free Cash Flow Firm Growth
-58.69% 52.34% -127.36% 142.71% -18.26% -107.62% -312.94% - -517.93% -850.35% -9.38%
Invested Capital Growth
-6.89% -15.33% 0.28% -3.08% -6.24% -1.40% 6.64% - 13.26% 12.00% 6.09%
Revenue Q/Q Growth
-8.65% 28.84% -4.33% 7.41% -17.03% 5.91% 10.54% - -13.64% 7.43% 0.10%
EBITDA Q/Q Growth
-101.83% 129.19% -336.03% 136.00% -474.56% -0.20% 74.11% - 0.00% 65.67% -92.30%
EBIT Q/Q Growth
-85.04% 98.15% -2,698.92% 102.96% -5,861.04% -5.73% 55.59% - -1,174.37% 59.13% -72.12%
NOPAT Q/Q Growth
-77.97% 100.22% -23,779.26% 102.82% -6,021.62% -2.28% 53.50% - -957.69% 59.17% -69.36%
Net Income Q/Q Growth
-244.55% 94.66% -350.52% -32.42% -91.65% -11.33% 32.26% - -306.10% 34.74% 20.93%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-252.71% 132.38% -83.24% 1,915.54% -192.07% 115.98% -595.27% - -156.00% 219.24% -74.04%
Free Cash Flow Firm Q/Q Growth
137.69% 277.55% -110.54% 256.74% 31.04% -135.18% -471.43% - -61.17% 19.99% 34.23%
Invested Capital Q/Q Growth
4.95% -6.08% -0.70% -6.57% 7.60% -1.23% 7.40% - 9.43% -2.33% 1.73%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
88.66% 89.69% 85.44% 88.46% 85.62% 86.18% 88.05% - 86.20% 87.44% 85.37%
EBITDA Margin
-17.45% 3.95% -9.75% 3.27% -14.75% -13.96% -3.27% - -15.39% -4.92% -9.45%
Operating Margin
-22.47% -0.12% -9.64% 0.25% -18.07% -17.45% -7.34% - -18.82% -7.15% -12.10%
EBIT Margin
-22.74% -0.33% -9.57% 0.26% -18.30% -18.26% -7.34% - -18.58% -7.07% -12.15%
Profit (Net Income) Margin
-24.68% -1.02% -4.82% -5.94% -13.72% -14.42% -8.84% - -16.50% -10.02% -7.92%
Tax Burden Percent
144.78% -22.16% 431.25% 173,600.00% 142.42% 144.18% 299.40% - 141.83% 270.95% 186.92%
Interest Burden Percent
74.96% -1,411.83% 11.68% -1.30% 52.66% 54.78% 40.23% - 62.62% 52.34% 34.85%
Effective Tax Rate
0.00% 122.16% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-11.78% 0.02% -6.15% 0.18% -11.87% -11.60% -4.78% - -12.33% -4.91% -8.01%
ROIC Less NNEP Spread (ROIC-NNEP)
-10.33% 0.24% -6.50% 1.30% -11.69% -11.23% -4.08% - -11.84% -4.13% -8.10%
Return on Net Nonoperating Assets (RNNOA)
5.40% -0.13% 3.72% -0.78% 6.57% 6.48% 2.32% - 7.16% 2.52% 4.84%
Return on Equity (ROE)
-6.37% -0.10% -2.43% -0.60% -5.29% -5.12% -2.46% - -5.17% -2.39% -3.17%
Cash Return on Invested Capital (CROIC)
-1.75% 10.63% -6.80% -1.84% 2.25% -5.72% -13.01% - -19.46% -17.04% -12.21%
Operating Return on Assets (OROA)
-6.92% -0.11% -3.24% 0.09% -6.53% -6.44% -2.58% - -5.98% -2.35% -4.06%
Return on Assets (ROA)
-7.51% -0.34% -1.63% -2.07% -4.90% -5.09% -3.11% - -5.31% -3.34% -2.65%
Return on Common Equity (ROCE)
-6.37% -0.10% -2.43% -0.60% -5.29% -5.12% -2.46% - -5.17% -2.39% -3.17%
Return on Equity Simple (ROE_SIMPLE)
-4.75% -2.63% -1.23% 0.00% -2.48% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.47 0.01 -1.84 0.05 -3.07 -3.14 -1.46 0.42 -3.56 -1.45 -2.46
NOPAT Margin
-15.73% 0.03% -6.75% 0.18% -12.65% -12.22% -5.14% - -13.17% -5.01% -8.47%
Net Nonoperating Expense Percent (NNEP)
-1.45% -0.22% 0.35% -1.12% -0.17% -0.37% -0.69% - -0.49% -0.79% 0.09%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.02% -1.14% -1.18% -0.54% 0.12% -1.05% -0.43% -0.72%
Cost of Revenue to Revenue
11.34% 10.31% 14.56% 11.54% 14.38% 13.82% 11.95% - 13.80% 12.56% 14.63%
SG&A Expenses to Revenue
16.18% 12.44% 17.06% 17.54% 16.22% 17.06% 15.44% - 17.24% 16.34% 21.17%
R&D to Revenue
81.51% 65.96% 66.12% 57.75% 72.63% 73.05% 68.81% - 73.41% 66.59% 62.37%
Operating Expenses to Revenue
111.13% 89.81% 95.09% 88.21% 103.69% 103.63% 95.39% - 105.02% 94.59% 97.47%
Earnings before Interest and Taxes (EBIT)
-5.02 -0.09 -2.60 0.08 -4.44 -4.69 -2.08 -0.39 -5.02 -2.05 -3.53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-3.85 1.12 -2.65 0.96 -3.58 -3.58 -0.93 0.00 -4.16 -1.43 -2.75
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.05 1.72 2.15 2.80 2.27 1.98 2.35 - 1.53 3.86 2.91
Price to Tangible Book Value (P/TBV)
2.67 2.24 2.79 3.61 2.92 2.55 3.02 - 1.86 4.67 3.51
Price to Revenue (P/Rev)
5.76 4.61 5.61 6.97 5.59 4.94 5.87 - 4.61 11.35 8.54
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.29 2.69 3.73 5.58 4.03 3.34 4.03 - 2.41 8.82 6.15
Enterprise Value to Revenue (EV/Rev)
4.23 3.08 4.11 5.46 4.15 3.49 4.48 - 2.74 9.49 6.69
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 1,728.21 168.11 132.61 167.11 0.00 - 0.00 288.60 69.70
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 23.24 0.00 0.00 173.34 0.00 0.00 - 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.02 0.01 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to Equity
0.01 0.01 0.01 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Financial Leverage
-0.52 -0.53 -0.57 -0.60 -0.56 -0.58 -0.57 - -0.60 -0.61 -0.60
Leverage Ratio
1.17 1.15 1.15 1.15 1.15 1.14 1.14 - 1.15 1.15 1.14
Compound Leverage Factor
0.88 -16.23 0.13 -0.02 0.61 0.62 0.46 - 0.72 0.60 0.40
Debt to Total Capital
2.29% 2.07% 0.98% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.98% 0.97% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
1.31% 1.10% 0.98% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Common Equity to Total Capital
97.71% 97.93% 99.02% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00% 100.00%
Debt to EBITDA
-0.55 -0.91 -0.36 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Debt to EBITDA
12.63 24.68 21.10 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.31 -0.48 -0.36 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Debt to NOPAT
-0.56 -0.76 -0.36 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Debt to NOPAT
12.86 20.55 21.11 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.32 -0.40 -0.36 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Altman Z-Score
9.27 8.58 9.86 11.67 10.02 9.58 11.23 - 7.23 16.30 13.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.69 8.30 7.60 7.09 7.45 8.58 8.68 - 10.26 10.12 10.88
Quick Ratio
6.79 7.68 7.03 6.51 6.77 7.86 8.05 - 9.48 9.37 10.13
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
5.41 20 -2.15 3.38 4.42 -1.56 -8.89 -11 -18 -15 -9.73
Operating Cash Flow to CapEx
-813.05% 391.45% 96.38% 781.54% -2,380.71% 171.20% -1,375.35% - -211.02% 918.77% 140.26%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.30 0.33 0.34 0.35 0.36 0.35 0.35 - 0.32 0.33 0.33
Accounts Receivable Turnover
2.72 2.92 2.92 3.17 2.93 2.94 2.43 - 2.51 2.78 2.42
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Fixed Asset Turnover
13.46 14.40 14.97 15.72 15.89 15.96 16.69 - 14.42 15.16 15.35
Accounts Payable Turnover
5.87 9.15 7.33 11.20 6.35 10.04 7.38 - 5.86 8.76 10.15
Days Sales Outstanding (DSO)
134.37 124.80 124.85 115.22 124.53 124.13 149.91 - 145.66 131.51 150.80
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Payable Outstanding (DPO)
62.14 39.87 49.81 32.58 57.48 36.37 49.49 - 62.29 41.68 35.95
Cash Conversion Cycle (CCC)
72.23 84.93 75.04 82.65 67.06 87.77 100.42 - 83.37 89.83 114.85
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
120 113 112 105 113 111 119 117 128 125 127
Invested Capital Turnover
0.75 0.80 0.91 1.01 0.94 0.95 0.93 - 0.94 0.98 0.95
Increase / (Decrease) in Invested Capital
-8.88 -20 0.32 -3.32 -7.49 -1.58 7.44 12 15 13 7.27
Enterprise Value (EV)
394 304 418 583 453 371 481 - 308 1,098 779
Market Capitalization
537 455 572 745 610 526 631 - 518 1,314 995
Book Value per Share
$11.10 $11.19 $11.22 $11.28 $11.30 $11.12 $11.25 $14.01 $12.19 $12.21 $12.16
Tangible Book Value per Share
$8.52 $8.61 $8.67 $8.73 $8.79 $8.62 $8.76 $11.54 $10.05 $10.09 $10.07
Total Capital
269 269 268 267 269 266 269 336 338 340 342
Total Debt
6.16 5.58 2.63 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
3.53 2.96 2.63 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-142 -151 -154 -162 -157 -155 -149 -220 -211 -216 -216
Capital Expenditures (CapEx)
0.90 0.61 0.41 1.03 0.31 0.69 0.43 1.49 2.32 0.63 1.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)
34 29 27 24 32 30 40 36 43 40 40
Debt-free Net Working Capital (DFNWC)
182 185 183 186 188 184 190 256 253 255 256
Net Working Capital (NWC)
179 182 183 186 188 184 190 256 253 255 256
Net Nonoperating Expense (NNE)
1.98 0.30 -0.53 1.79 0.26 0.57 1.05 1.51 0.90 1.46 -0.16
Net Nonoperating Obligations (NNO)
-142 -151 -154 -162 -157 -155 -149 -220 -211 -216 -216
Total Depreciation and Amortization (D&A)
1.17 1.22 -0.05 0.88 0.86 1.11 1.16 0.39 0.86 0.62 0.79
Debt-free, Cash-free Net Working Capital to Revenue
35.99% 28.96% 26.39% 22.63% 28.93% 28.03% 37.61% - 38.20% 34.24% 34.34%
Debt-free Net Working Capital to Revenue
194.84% 187.25% 179.62% 173.76% 172.17% 173.45% 176.41% - 225.57% 220.51% 219.52%
Net Working Capital to Revenue
192.01% 184.60% 179.62% 173.76% 172.17% 173.45% 176.41% - 225.57% 220.51% 219.52%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.23) ($0.01) ($0.06) ($0.07) $0.00 $0.00 $0.00 $0.00 ($0.16) ($0.10) ($0.08)
Adjusted Weighted Average Basic Shares Outstanding
23.51M 23.63M 23.68M 23.61M 23.76M 23.90M 23.94M 24.30M 27.68M 28.00M 28.32M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
23.58M 23.69M 23.63M 23.61M 23.92M 23.88M 24.02M 24.30M 27.86M 28.15M 28.53M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
23.58M 23.69M 23.63M 23.81M 23.92M 23.88M 24.02M 27.75M 27.86M 28.15M 28.53M
Normalized Net Operating Profit after Tax (NOPAT)
-3.47 -0.02 -1.84 0.05 -3.07 -3.14 -1.46 -0.28 -3.56 -1.45 -2.46
Normalized NOPAT Margin
-15.73% -0.09% -6.75% 0.18% -12.65% -12.22% -5.14% - -13.17% -5.01% -8.47%
Pre Tax Income Margin
-17.05% 4.62% -1.12% 0.00% -9.64% -10.00% -2.95% - -11.63% -3.70% -4.24%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Augmented Payout Ratio
-59.75% -136.26% -323.56% -96.24% -107.70% -112.54% -72.28% - 0.00% -9.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Ceva’s Q2 2026 results show improving revenue and cash generation, but the company remains unprofitable. Revenue reached $29.0 million, up 13.1% from $25.7 million in Q2 2025 and 27.4% from Q2 2024. Revenue has generally recovered from the 2023 lows, although it remains below the $30.1 million reported in Q3 2022.

Gross profit increased to $25.4 million in Q2 2026, producing an 87.4% gross margin. This improved from 86.2% in Q2 2025, though it was below the 89.7% margin recorded in Q2 2024. Operating expenses declined year over year to $27.5 million, helping narrow the operating loss to $2.1 million from $4.5 million in Q2 2025.

Ceva generated $5.8 million of operating cash flow in Q2 2026, compared with $1.2 million in the year-ago quarter and negative operating cash flow of $4.9 million in Q1 2026. However, this improvement was partly supported by non-cash adjustments and working-capital changes rather than positive net income. The company still reported a $2.9 million net loss, its sixth consecutive quarterly loss in the provided 2025-2026 results.

The balance sheet remains a significant strength. As of June 30, 2026, Ceva held $44.3 million in cash and $171.3 million in short-term investments, or approximately $215.6 million in highly liquid assets. Total liabilities were only $51.6 million, and the company reported no short-term debt or capital lease obligations in the latest balance sheet. Retained earnings, however, declined to a deficit of $7.4 million, reflecting the effect of ongoing losses.

  • Revenue recovery: Q2 2026 revenue rose 13.1% year over year to $29.0 million, continuing the recovery from the weaker 2023 revenue levels.
  • Improved operating performance: The operating loss narrowed to $2.1 million from $4.5 million a year earlier as revenue grew and total operating expenses declined.
  • Strong liquidity: Cash and short-term investments totaled approximately $215.6 million at the end of Q2 2026, providing substantial financial flexibility.
  • Low balance-sheet leverage: Total liabilities of $51.6 million were modest relative to $340.2 million of shareholders’ equity, and no short-term debt was reported in Q2 2026.
  • Better operating cash flow: Operating cash flow improved to $5.8 million in Q2 2026 from $1.2 million in Q2 2025 and negative cash flow in Q1 2026.
  • Investment portfolio activity: Investing cash flow was positive at $17.1 million, but this primarily reflected $41.3 million of investment sales and maturities compared with $23.5 million of new investment purchases. This is more indicative of portfolio management than recurring business cash generation.
  • High research spending: Research and development expense was $19.3 million, equal to roughly two-thirds of quarterly revenue. This spending may support future technology growth but continues to weigh heavily on current profitability.
  • Persistent net losses: Ceva recorded a $2.9 million net loss in Q2 2026, following losses of $4.5 million in Q1 2026 and $1.1 million in Q4 2025.
  • Continued shareholder dilution: Weighted average basic shares rose to approximately 28.0 million in Q2 2026 from 23.9 million in Q2 2025. The increase coincided with common-equity issuance, which can reduce per-share upside for existing investors.
  • Negative retained earnings: Retained earnings fell from a positive $14.6 million in Q1 2024 to a deficit of $7.4 million by Q2 2026, indicating that cumulative losses are eroding internally generated equity.

Overall, Ceva’s financial position is well funded and Q2 2026 showed meaningful improvement in revenue, margins and operating cash flow. The main hurdles are converting revenue growth into sustained operating profitability, reducing reliance on investment-portfolio cash movements and managing dilution from equity issuance.

11/13/26 08:01 PM ETAI Generated. May Contain Errors.

Ceva Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ceva's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Ceva's net income appears to be on a downward trend, with a most recent value of -$10.64 million in 2025, compared with $6.27 million in 2015. The previous period was -$8.79 million in 2024. View Ceva's forecast to see where analysts expect Ceva to go next.

Ceva's total operating income in 2025 was -$11.35 million, based on the following breakdown:
  • Total Gross Profit: $95.44 million
  • Total Operating Expenses: $106.79 million

Over the last 10 years, Ceva's total revenue changed from $59.50 million in 2015 to $109.60 million in 2025, a change of 84.2%.

In the past 13 quarters, Ceva's cash and equivalents has ranged from $13.23 million in Q3 2024 to $44.30 million in Q2 2026, and is currently $29.61 million as of their latest financial filing in Q3 2026.

Ceva had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2015.

Over the last 10 years, Ceva's book value per share changed from 9.10 in 2015 to 14.01 in 2025, a change of 53.9%.



Financial statements for NASDAQ:CEVA last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners